Sagdic MF, Tunc E, Kulturoglu MO, Yildirim OA, Dogan L. HER2 IHC score as a predictor of pathologic complete response in HER2-positive breast cancer after neoadjuvant therapy. Ann Med Res [Internet]. 2026 Aug. 25 [cited 2026 Sep. 5];33(8):369-74. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/4937